cytarabine

The drug is used to achieve and maintain remission in acute non-lymphoblastic leukemias in adults and children, as well as for the treatment of other types of leukemia (e.g., acute lymphocytic or chronic myeloblastic leukemia). It is also used in combination therapy for non-Hodgkin lymphomas in children.

Form: solution for injection

ATC: L01BC01

Manufacturer: Venus Remedies Limited

The drug is used to achieve and maintain remission in acute non-lymphoblastic leukemias in adults and children, as well as for the treatment of other types of leukemias (e.g., acute lymphocytic or chronic myeloblastic) and non-Hodgkin lymphomas in children. It is also used for the prevention or treatment of leukemic meningitis.

Form: lyophilisate for solution for injection

ATC: L01BC01

Manufacturer: Latina Pharma S.p.A. (manufacturing, primary packaging, secondary packaging, quality control, batch release, stability testing)

The drug is used to achieve and maintain remission in acute non-lymphoblastic leukemias in adults and children, as well as for the treatment of other types of leukemia (e.g., acute lymphocytic or chronic myeloblastic) and non-Hodgkin lymphomas in children. It is also used for the prevention or treatment of leukemic meningitis.

Form: lyophilisate for solution for injection

ATC: L01BC01

Manufacturer: Latina Pharma S.p.A.